Annual Net Margin
12.69%
+44.02%+140.50%
December 31, 2023
Summary
- As of February 8, 2025, PLX annual net profit margin is 12.69%, with the most recent change of +44.02% (+140.50%) on December 31, 2023.
- During the last 3 years, PLX annual net margin has risen by +23.06% (+222.37%).
- PLX annual net margin is now at all-time high.
Performance
PLX Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Margin
18.02%
+34.37%+210.21%
September 30, 2024
Summary
- As of February 8, 2025, PLX quarterly net profit margin is 18.02%, with the most recent change of +34.37% (+210.21%) on September 30, 2024.
- Over the past year, PLX quarterly net margin has increased by +35.92% (+200.67%).
- PLX quarterly net margin is now -78.18% below its all-time high of 82.60%, reached on December 31, 2014.
Performance
PLX Quarterly Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Margin Formula
Net Margin = Net Income
Revenue ✕ 100%
Revenue ✕ 100%
PLX Net Margin Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +140.5% | +200.7% |
| 3 y3 years | +222.4% | +200.7% |
| 5 y5 years | +116.4% | +200.7% |
PLX Net Margin Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +117.6% | -67.3% | +114.7% |
| 5 y | 5-year | at high | +117.6% | -67.3% | +110.3% |
| alltime | all time | at high | +100.2% | -78.2% | +100.0% |
Protalix BioTherapeutics Net Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 18.02%(-210.2%) |
| Jun 2024 | - | -16.35%(-86.7%) |
| Mar 2024 | - | -122.60%(+112.7%) |
| Dec 2023 | 12.69%(-140.5%) | -57.64%(+222.0%) |
| Sep 2023 | - | -17.90%(-132.5%) |
| Jun 2023 | - | 55.14%(-268.8%) |
| Mar 2023 | - | -32.66%(-24.7%) |
| Dec 2022 | -31.33%(-56.4%) | -43.40%(+72.6%) |
| Sep 2022 | - | -25.15%(-58.7%) |
| Jun 2022 | - | -60.94%(+328.9%) |
| Mar 2022 | - | -14.21%(-81.8%) |
| Dec 2021 | -71.92%(+593.5%) | -77.99%(+123.9%) |
| Sep 2021 | - | -34.83%(-80.1%) |
| Jun 2021 | - | -174.90%(+261.6%) |
| Mar 2021 | - | -48.37%(-2471.1%) |
| Dec 2020 | -10.37%(-69.0%) | 2.04%(-105.0%) |
| Sep 2020 | - | -41.12%(+8.7%) |
| Jun 2020 | - | -37.84%(-591.4%) |
| Mar 2020 | - | 7.70%(+369.5%) |
| Dec 2019 | -33.42%(-56.7%) | 1.64%(-106.6%) |
| Sep 2019 | - | -24.99%(-60.5%) |
| Jun 2019 | - | -63.22%(-9.2%) |
| Mar 2019 | - | -69.59%(+32.6%) |
| Dec 2018 | -77.27%(-80.5%) | -52.49%(+21.6%) |
| Sep 2018 | - | -43.15%(-75.3%) |
| Jun 2018 | - | -174.91%(+62.2%) |
| Mar 2018 | - | -107.82%(-65.1%) |
| Dec 2017 | -395.86%(+24.0%) | -309.06%(+103.4%) |
| Sep 2017 | - | -151.97%(-2246.5%) |
| Jun 2017 | - | 7.08%(-100.3%) |
| Mar 2017 | - | -2047.35%(+1523.7%) |
| Dec 2016 | -319.22% | -126.09%(-19.2%) |
| Sep 2016 | - | -156.10%(-74.6%) |
| Jun 2016 | - | -613.51%(-51.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2016 | - | -1266.27%(+342.9%) |
| Sep 2015 | - | -285.93%(-24.7%) |
| Jun 2015 | - | -379.57%(+7.5%) |
| Mar 2015 | - | -352.96%(-527.3%) |
| Dec 2014 | -849.93%(+2418.3%) | 82.60%(-138.2%) |
| Sep 2014 | - | -216.08%(-5.1%) |
| Jun 2014 | - | -227.81%(+129.0%) |
| Mar 2014 | - | -99.49%(-41.8%) |
| Sep 2013 | - | -171.09%(-23.3%) |
| Jun 2013 | - | -223.14%(+104.9%) |
| Mar 2013 | - | -108.90%(-99.5%) |
| Dec 2012 | -33.75%(-97.3%) | -20.58 K%(>+9900.0%) |
| Sep 2012 | - | -101.65%(-366.3%) |
| Jun 2012 | - | 38.17%(-124.1%) |
| Mar 2012 | - | -158.37%(-87.8%) |
| Dec 2011 | -1230.76%(+377.2%) | -1293.61%(+30.7%) |
| Sep 2011 | - | -989.41%(-44.8%) |
| Jun 2011 | - | -1791.75%(+2028.0%) |
| Mar 2011 | - | -84.20%(-43.0%) |
| Dec 2010 | -257.90%(-96.8%) | -147.59%(+89.9%) |
| Sep 2010 | - | -77.70%(-91.2%) |
| Jun 2010 | - | -880.02%(-6.3%) |
| Mar 2010 | - | -939.20%(-75.6%) |
| Dec 2009 | -8103.09%(+111.5%) | -3849.48%(-99.9%) |
| Dec 2005 | -3830.67%(+580.4%) | - |
| Dec 2004 | -563.02%(+1905.8%) | - |
| Jun 2001 | - | -5.25 M%(-69.5%) |
| Mar 2001 | - | -17.23 M%(+1329.7%) |
| Jun 2000 | - | -1.20 M%(-70.9%) |
| Mar 2000 | - | -4.14 M%(>+9900.0%) |
| Dec 1999 | -28.07%(+96.7%) | -869.61%(+587.4%) |
| Sep 1999 | - | -126.51%(+3878.3%) |
| Jun 1999 | - | -3.18%(-81.5%) |
| Mar 1999 | - | -17.20% |
| Dec 1998 | -14.27% | - |
FAQ
- What is Protalix BioTherapeutics annual net profit margin?
- What is the all time high annual net margin for Protalix BioTherapeutics?
- What is Protalix BioTherapeutics annual net margin year-on-year change?
- What is Protalix BioTherapeutics quarterly net profit margin?
- What is the all time high quarterly net margin for Protalix BioTherapeutics?
- What is Protalix BioTherapeutics quarterly net margin year-on-year change?
What is Protalix BioTherapeutics annual net profit margin?
The current annual net margin of PLX is 12.69%
What is the all time high annual net margin for Protalix BioTherapeutics?
Protalix BioTherapeutics all-time high annual net profit margin is 12.69%
What is Protalix BioTherapeutics annual net margin year-on-year change?
Over the past year, PLX annual net profit margin has changed by +44.02% (+140.50%)
What is Protalix BioTherapeutics quarterly net profit margin?
The current quarterly net margin of PLX is 18.02%
What is the all time high quarterly net margin for Protalix BioTherapeutics?
Protalix BioTherapeutics all-time high quarterly net profit margin is 82.60%
What is Protalix BioTherapeutics quarterly net margin year-on-year change?
Over the past year, PLX quarterly net profit margin has changed by +35.92% (+200.67%)